Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)
| 21.27 Delayed Data As of Oct 15 |  -0.03 / -0.14%Today’s Change | 18.54 Today|||52-Week Range 40.14 | -3.45% Year-to-Date |
Latest DRNA News | Press Releases
| Here's Why Inhibrx Stock Is on the Move Today Oct 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 21.30 |
| Today’s open | 20.94 |
| Day’s range | 20.90 - 21.35 |
| Volume | 18,707 |
| Average volume (3 months) | 924,468 |
| Market cap | $1.5B |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | +13.67% |
| Earnings growth (this year) | -19.38% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +587.36% |
| P/E ratio | NM |
| Price/Sales | 9.95 |
| Price/Book | 10.95 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCYCBicycle Therapeutics... | -0.11 | -0.18% |
| CDMOAvid Bioservices Inc | +1.02 | +4.11% |
| OCGNOcugen Inc | -1.39 | -13.83% |
| KDMNKadmon Holdings Inc | -0.13 | -1.47% |
Data as of 5:59pm ET, 10/15/2021
Financials
| Next reporting date | November 8, 2021 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $164.3M |
| Annual profit (last year) | -$112.7M |
| Net profit margin | -68.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
